HEADER SIGNALING PROTEIN 20-MAR-15 2N14 TITLE MDMX-295 COMPND MOL_ID: 1; COMPND 2 MOLECULE: PROTEIN MDM4; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: UNP RESIDUES 23-111; COMPND 5 SYNONYM: DOUBLE MINUTE 4 PROTEIN, MDM2-LIKE P53-BINDING PROTEIN, COMPND 6 PROTEIN MDMX, P53-BINDING PROTEIN MDM4; COMPND 7 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: MDM4, MDMX; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 8 EXPRESSION_SYSTEM_VECTOR: BL21(DE3) KEYWDS MDMX, SIGNALING PROTEIN EXPDTA SOLUTION NMR NUMMDL 20 AUTHOR C.R.GRACE,R.W.KRIWACKI REVDAT 3 01-MAY-24 2N14 1 REMARK REVDAT 2 04-MAY-16 2N14 1 JRNL REVDAT 1 27-JAN-16 2N14 0 JRNL AUTH C.R.GRACE,D.BAN,J.MIN,A.MAYASUNDARI,L.MIN,K.E.FINCH, JRNL AUTH 2 L.GRIFFITHS,N.BHARATHAM,D.BASHFORD,R.KIPLIN GUY,M.A.DYER, JRNL AUTH 3 R.W.KRIWACKI JRNL TITL MONITORING LIGAND-INDUCED PROTEIN ORDERING IN DRUG JRNL TITL 2 DISCOVERY. JRNL REF J.MOL.BIOL. V. 428 1290 2016 JRNL REFN ISSN 0022-2836 JRNL PMID 26812210 JRNL DOI 10.1016/J.JMB.2016.01.016 REMARK 2 REMARK 2 RESOLUTION. NOT APPLICABLE. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : TOPSPIN, CYANA REMARK 3 AUTHORS : BRUKER BIOSPIN (TOPSPIN) REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 2N14 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 28-MAR-15. REMARK 100 THE DEPOSITION ID IS D_1000104289. REMARK 210 REMARK 210 EXPERIMENTAL DETAILS REMARK 210 EXPERIMENT TYPE : NMR REMARK 210 TEMPERATURE (KELVIN) : 298 REMARK 210 PH : 6.5 REMARK 210 IONIC STRENGTH : 200 REMARK 210 PRESSURE : AMBIENT REMARK 210 SAMPLE CONTENTS : 0.5 MM [U-100% 13C; U-100% 15N] REMARK 210 PROTEIN_1, 0.6 MM PROTEIN_2, 90% REMARK 210 H2O/10% D2O REMARK 210 REMARK 210 NMR EXPERIMENTS CONDUCTED : 2D 1H-15N HSQC; 2D 1H-13C HSQC; REMARK 210 2D 1H-13C HSQC AROMATIC; 3D HNCA; REMARK 210 3D HNCACB; 3D CBCA(CO)NH; 3D REMARK 210 HNCO; 3D HCCH-TOCSY; 3D 1H-15N REMARK 210 NOESY; 3D 1H-15N TOCSY; 3D 1H- REMARK 210 13C NOESY ALIPHATIC; 3D 1H-13C REMARK 210 NOESY AROMATIC REMARK 210 SPECTROMETER FIELD STRENGTH : 600 MHZ; 800 MHZ REMARK 210 SPECTROMETER MODEL : AVANCE REMARK 210 SPECTROMETER MANUFACTURER : BRUKER REMARK 210 REMARK 210 STRUCTURE DETERMINATION. REMARK 210 SOFTWARE USED : TOPSPIN, CARA, CYANA REMARK 210 METHOD USED : TORSION ANGLE DYNAMICS REMARK 210 REMARK 210 CONFORMERS, NUMBER CALCULATED : 100 REMARK 210 CONFORMERS, NUMBER SUBMITTED : 20 REMARK 210 CONFORMERS, SELECTION CRITERIA : TARGET FUNCTION REMARK 210 REMARK 210 BEST REPRESENTATIVE CONFORMER IN THIS ENSEMBLE : 1 REMARK 210 REMARK 210 REMARK: NULL REMARK 215 REMARK 215 NMR STUDY REMARK 215 THE COORDINATES IN THIS ENTRY WERE GENERATED FROM SOLUTION REMARK 215 NMR DATA. PROTEIN DATA BANK CONVENTIONS REQUIRE THAT REMARK 215 CRYST1 AND SCALE RECORDS BE INCLUDED, BUT THE VALUES ON REMARK 215 THESE RECORDS ARE MEANINGLESS. REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 2 ARG A 87 NE - CZ - NH1 ANGL. DEV. = 3.0 DEGREES REMARK 500 3 ARG A 87 NE - CZ - NH1 ANGL. DEV. = 4.5 DEGREES REMARK 500 5 ARG A 87 NE - CZ - NH1 ANGL. DEV. = 4.4 DEGREES REMARK 500 6 ARG A 87 NE - CZ - NH1 ANGL. DEV. = 4.6 DEGREES REMARK 500 6 ARG A 103 NE - CZ - NH1 ANGL. DEV. = 3.2 DEGREES REMARK 500 7 ARG A 87 NE - CZ - NH1 ANGL. DEV. = 3.7 DEGREES REMARK 500 8 ARG A 87 NE - CZ - NH1 ANGL. DEV. = 3.9 DEGREES REMARK 500 9 ARG A 87 NE - CZ - NH1 ANGL. DEV. = 3.9 DEGREES REMARK 500 10 ARG A 103 NE - CZ - NH1 ANGL. DEV. = 3.1 DEGREES REMARK 500 12 ARG A 103 NE - CZ - NH1 ANGL. DEV. = 3.0 DEGREES REMARK 500 16 VAL A 52 CA - CB - CG2 ANGL. DEV. = 9.9 DEGREES REMARK 500 16 ARG A 87 NE - CZ - NH1 ANGL. DEV. = 4.2 DEGREES REMARK 500 17 ARG A 87 NE - CZ - NH1 ANGL. DEV. = 3.6 DEGREES REMARK 500 18 ARG A 87 NE - CZ - NH1 ANGL. DEV. = 4.0 DEGREES REMARK 500 18 ARG A 103 NE - CZ - NH1 ANGL. DEV. = 3.0 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 1 ASN A 25 48.04 -86.27 REMARK 500 1 ALA A 42 -157.75 -85.43 REMARK 500 1 MET A 46 48.65 -74.26 REMARK 500 1 GLU A 70 86.59 -157.40 REMARK 500 1 ASN A 105 -62.97 -93.14 REMARK 500 3 ASN A 25 36.52 -82.40 REMARK 500 3 GLU A 45 19.29 -142.25 REMARK 500 3 MET A 46 38.82 -71.54 REMARK 500 4 ASN A 25 54.42 -91.83 REMARK 500 4 CYS A 76 29.69 -145.24 REMARK 500 5 ASN A 25 32.62 -80.05 REMARK 500 5 MET A 46 47.59 -78.08 REMARK 500 5 CYS A 76 29.57 -145.95 REMARK 500 5 ASN A 105 -88.87 -96.70 REMARK 500 6 GLN A 26 -160.14 -163.23 REMARK 500 6 MET A 46 49.83 -75.97 REMARK 500 6 CYS A 76 30.69 -88.53 REMARK 500 6 ASN A 105 -65.57 -91.94 REMARK 500 7 ASN A 25 35.43 -82.15 REMARK 500 7 ALA A 42 -161.20 -79.36 REMARK 500 7 GLU A 45 19.62 -141.39 REMARK 500 7 MET A 46 47.55 -77.64 REMARK 500 7 ASN A 105 -71.17 -97.27 REMARK 500 8 ASN A 25 36.70 -83.31 REMARK 500 8 GLU A 45 11.26 -141.62 REMARK 500 9 CYS A 76 24.71 -157.03 REMARK 500 10 ASN A 25 27.84 -77.36 REMARK 500 10 ALA A 42 -161.12 -79.89 REMARK 500 10 CYS A 76 24.87 -148.98 REMARK 500 10 THR A 108 -168.05 46.82 REMARK 500 11 ASN A 25 57.20 -92.43 REMARK 500 11 GLU A 45 20.26 -140.27 REMARK 500 11 MET A 46 42.48 -77.63 REMARK 500 11 CYS A 76 23.62 -150.44 REMARK 500 11 VAL A 107 41.42 -75.21 REMARK 500 12 ASN A 25 35.32 -81.18 REMARK 500 12 GLU A 45 14.80 -143.59 REMARK 500 12 CYS A 76 29.24 -148.62 REMARK 500 12 ASN A 105 -71.31 -82.87 REMARK 500 13 ASN A 25 32.52 -82.47 REMARK 500 13 CYS A 76 28.62 -146.19 REMARK 500 13 VAL A 107 39.94 -78.85 REMARK 500 14 ASN A 25 33.75 -78.51 REMARK 500 14 CYS A 76 25.28 -146.74 REMARK 500 14 ASN A 105 -92.97 -87.65 REMARK 500 15 ASN A 25 45.99 -86.39 REMARK 500 15 ALA A 42 -156.23 -82.24 REMARK 500 15 CYS A 76 24.24 -148.02 REMARK 500 15 ASN A 105 -71.70 -101.96 REMARK 500 16 ASN A 25 35.14 -81.26 REMARK 500 REMARK 500 THIS ENTRY HAS 75 RAMACHANDRAN OUTLIERS. REMARK 500 REMARK 500 REMARK: NULL REMARK 600 REMARK 600 HETEROGEN REMARK 600 REMARK 600 49H IS REFERRED AS SJ5/SJ295 IN THE PAPER REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 49H A 200 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 25546 RELATED DB: BMRB REMARK 900 RELATED ID: 2N0U RELATED DB: PDB REMARK 900 RELATED ID: 2N0W RELATED DB: PDB REMARK 900 RELATED ID: 2N06 RELATED DB: PDB DBREF 2N14 A 23 111 UNP O15151 MDM4_HUMAN 23 111 SEQRES 1 A 89 GLN ILE ASN GLN VAL ARG PRO LYS LEU PRO LEU LEU LYS SEQRES 2 A 89 ILE LEU HIS ALA ALA GLY ALA GLN GLY GLU MET PHE THR SEQRES 3 A 89 VAL LYS GLU VAL MET HIS TYR LEU GLY GLN TYR ILE MET SEQRES 4 A 89 VAL LYS GLN LEU TYR ASP GLN GLN GLU GLN HIS MET VAL SEQRES 5 A 89 TYR CYS GLY GLY ASP LEU LEU GLY GLU LEU LEU GLY ARG SEQRES 6 A 89 GLN SER PHE SER VAL LYS ASP PRO SER PRO LEU TYR ASP SEQRES 7 A 89 MET LEU ARG LYS ASN LEU VAL THR LEU ALA THR HET 49H A 200 70 HETNAM 49H 4-({(4S,5R)-4-(3-CHLOROPHENYL)-5-(4-CHLOROPHENYL)-2-[4- HETNAM 2 49H METHOXY-2-(PROPAN-2-YLOXY)PHENYL]-4,5-DIHYDRO-1H- HETNAM 3 49H IMIDAZOL-1-YL}CARBONYL)PIPERAZIN-2-ONE FORMUL 2 49H C30 H30 CL2 N4 O4 HELIX 1 1 LYS A 30 ALA A 39 1 10 HELIX 2 2 THR A 48 GLN A 64 1 17 HELIX 3 3 ASP A 79 GLY A 86 1 8 HELIX 4 4 PRO A 95 ARG A 103 1 9 SHEET 1 A 3 TYR A 66 ASP A 67 0 SHEET 2 A 3 GLU A 70 TYR A 75 -1 O MET A 73 N ASP A 67 SHEET 3 A 3 SER A 89 SER A 91 -1 O PHE A 90 N VAL A 74 SITE 1 AC1 8 MET A 53 LEU A 56 GLY A 57 ILE A 60 SITE 2 AC1 8 MET A 61 GLN A 71 HIS A 72 VAL A 92 CRYST1 1.000 1.000 1.000 90.00 90.00 90.00 P 1 1 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 1.000000 0.000000 0.000000 0.00000 SCALE2 0.000000 1.000000 0.000000 0.00000 SCALE3 0.000000 0.000000 1.000000 0.00000 MODEL 1